Total Payments
$1,048
2024 Payments
$163.41
Companies
10
Transactions
62
Medicare Patients
38
Medicare Billing
$254.60
Payment Breakdown by Category
Food & Beverage$1,016 (96.9%)
Other$32.64 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,016 | 61 | 96.9% |
| Long term medical supply or device loan | $32.64 | 1 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $677.98 | 41 | $0 (2024) |
| PFIZER INC. | $171.37 | 9 | $0 (2024) |
| QIAGEN, LLC | $40.44 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $39.33 | 3 | $0 (2019) |
| Baxter Healthcare | $32.64 | 1 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $32.10 | 2 | $0 (2017) |
| Biohaven Pharmaceuticals, Inc. | $19.22 | 1 | $0 (2021) |
| Novo Nordisk Inc | $13.07 | 1 | $0 (2020) |
| Abbott Laboratories | $11.17 | 1 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $10.97 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $163.41 | 7 | GlaxoSmithKline, LLC. ($101.29) |
| 2023 | $205.86 | 11 | PFIZER INC. ($108.14) |
| 2022 | $161.16 | 10 | GlaxoSmithKline, LLC. ($140.42) |
| 2021 | $224.44 | 14 | GlaxoSmithKline, LLC. ($205.22) |
| 2020 | $127.18 | 8 | GlaxoSmithKline, LLC. ($114.11) |
| 2019 | $88.07 | 6 | GlaxoSmithKline, LLC. ($59.66) |
| 2018 | $22.09 | 2 | Abbott Laboratories ($11.17) |
| 2017 | $56.08 | 4 | SANOFI-AVENTIS U.S. LLC ($32.10) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: RESPIRATORY | ||||||
| 08/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: RESPIRATORY | ||||||
| 08/20/2024 | Baxter Healthcare | Hillrom - Spot Vision Screener (Device) | Long term medical supply or device loan | In-kind items and services | $32.64 | General |
| Category: Physical Assessment, Vision | ||||||
| 08/01/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $29.48 | General |
| Category: VACCINES | ||||||
| 10/03/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: VACCINES | ||||||
| 09/16/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: VACCINES | ||||||
| 06/30/2023 | QIAGEN, LLC | — | Food and Beverage | Cash or cash equivalent | $21.26 | General |
| 06/29/2023 | QIAGEN, LLC | — | Food and Beverage | Cash or cash equivalent | $19.18 | General |
| 06/10/2023 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: VACCINES | ||||||
| 05/19/2023 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20 | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: VACCINES | ||||||
| 04/15/2023 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: VACCINES | ||||||
| 02/10/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: RESPIRATORY | ||||||
| 01/23/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: RESPIRATORY | ||||||
| 01/11/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: VACCINES | ||||||
| 01/05/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: RESPIRATORY | ||||||
| 09/16/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: RESPIRATORY | ||||||
| 06/27/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: RESPIRATORY | ||||||
| 05/26/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: RESPIRATORY | ||||||
| 05/01/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: VACCINES | ||||||
| 04/29/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 38 | 40 | $844.00 | $254.60 |
Total Patients
38
Total Services
40
Medicare Billing
$254.60
Procedure Codes
2
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83036 | Hemoglobin a1c level | Office | 2023 | 20 | 20 | $640.00 | $190.40 | 29.8% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 18 | 20 | $204.00 | $64.20 | 31.5% |
About Dr. Joseph Greco, MD
Dr. Joseph Greco, MD is a Hospice and Palliative Medicine healthcare provider based in Kennett Square, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083684252.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Greco, MD has received a total of $1,048 in payments from pharmaceutical and medical device companies, with $163.41 received in 2024. These payments were reported across 62 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,016).
As a Medicare-enrolled provider, Greco has provided services to 38 Medicare beneficiaries, totaling 40 services with total Medicare billing of $254.60. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospice and Palliative Medicine
- Other Specialties Family Medicine
- Location Kennett Square, PA
- Active Since 01/23/2006
- Last Updated 04/28/2023
- Taxonomy Code 207QH0002X
- Entity Type Individual
- NPI Number 1083684252
Products in Payments
- TRELEGY ELLIPTA (Drug) $662.82
- PREVNAR 20 (Biological) $138.84
- Hillrom - Spot Vision Screener (Device) $32.64
- TOUJEO (Drug) $32.10
- TRUMENBA (Biological) $19.52
- NURTEC ODT (Drug) $19.22
- MENVEO (Biological) $15.16
- SPIRIVA RESPIMAT (Drug) $14.23
- Ozempic (Drug) $13.07
- PREVNAR - 13 (Biological) $13.01
- Alere i (Device) $11.17
- ZOSTAVAX (Biological) $10.97
- TRADJENTA (Drug) $10.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.